| Phase 2 |
| NCT03383575 |
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome |
Acute Myeloid Leukemia |
Recruiting |
| NCT03683433 |
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute… |
Acute Bilineal Leukemia |
Recruiting |
| NCT06756308 |
A Study of Enasidenib in People With T-Cell Lymphoma |
T-cell Lymphoma |
Recruiting |
| NCT03728335 |
Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation |
Acute Myeloid Leukemia |
Recruiting |
| NCT06240754 |
Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations… |
Clonal Cytopenia of Undetermined Significance |
Recruiting |
| NCT06176989 |
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors |
Metastatic Chondrosarcoma |
Recruiting |
| NCT05401097 |
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of… |
Acute Myeloid Leukemia |
Recruiting |
| NCT05564390 |
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… |
Acute Myeloid Leukemia |
Recruiting |
| NCT06577441 |
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment… |
Myelodysplastic Syndrome |
Recruiting |
| NCT06672146 |
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has… |
Acute Myeloid Leukemia |
Recruiting |
| NCT04203316 |
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients… |
Recurrent Acute Myeloid Leukemia |
Active, Not Recruiting |
| Phase 1/2 |
| NCT02813135 |
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in… |
Pediatric Cancer |
Recruiting |
| NCT04774393 |
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for… |
Acute Myeloid Leukemia |
Recruiting |
| NCT02677922 |
A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase… |
Leukemia, Myeloid, Acute |
Active, Not Recruiting |
| Phase 1 |
| NCT05010772 |
Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or… |
Acute Myeloid Leukemia |
Recruiting |
| NCT05756777 |
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute… |
Acute Myeloid Leukemia (AML) |
Recruiting |
| NCT02632708 |
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy… |
Newly Diagnosed Acute Myeloid Leukemia (AML) |
Active, Not Recruiting |